Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Gene Silencing Market Today And What Is Its Future Size?

The market size for gene silencing has seen a rapid expansion in recent years. Projected growth indicates an increase from $5.97 billion in 2024 to $6.69 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.0%. The historic growth pattern is associated with the intensifying research in genetical therapies, preliminary advancements in RNA interference, escalating frequency of genetic disorders, burgeoning investments in biotechnology, and the expansion of biopharmaceutical manufacturing capabilities.

Predictions indicate a speedy expansion for the gene silencing market in the upcoming years, estimating it to reach $10.74 billion by 2029, with a compound annual growth rate (CAGR) of 12.6%. This anticipated growth throughout the forecast period is linked to factors such as the growing utilization in the treatment of uncommon diseases, advancement in delivery systems’ technology, an upsurge in the need for personalized medicine, encouraging government initiatives, and rising collaboration between pharmaceutical and biotechnological organizations. Some dominant trends throughout this forecast period include breakthroughs in targeted gene therapies, the popularity of CRISPR-based silencing methods, heightened concentration on rare and orphan diseases, the development of nanoparticle delivery technologies, and the outreach to agricultural gene silencing applications.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24224&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Gene Silencing Market?

The gene silencing market is anticipated to expand owing to the escalating occurrence of genetic disorders. These disorders, which occur due to anomalies in a person’s DNA, are being increasingly identified due to developments in diagnostic technology, elevated consciousness, and widespread availability of genetic testing. The surge in genetic disorders is attributed to the increasing age of parents, which raises the probability of passing on genetic mutations to their children. Gene silencing presents an innovative solution to these disorders by specifically inhibiting the expression of errant or disease-causing genes. For example, statistics from Down Syndrome UK, a charity based in the UK, reveal that as of August 2023, Down syndrome impacted nearly 40,000 individuals in the UK, with roughly 1 in every 800 newborns diagnosed with the condition. As a result, the escalating occurrence of genetic disorders is contributing to the expansion of the gene silencing market.

Which Segmentation Categories Are Highlighted In The Gene Silencing Market Analysis?

The gene silencing market covered in this report is segmented –

1) By Type: Transcriptional, Post-Transcriptional, Meiotic

2) By Gene Silencing: RNA Interference (RNAi), Antisense Oligonucleotides (ASOs), Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing, Other Gene Silencings

3) By Application: Neurology, Oncology, Infectious Diseases, Metabolic Diseases, Therapeutics Manufacturing, Other Applications

4) By End-Users: Pharmaceutical And Biotechnology Companies, Research Institutes and Academic Centers, Hospitals, Clinics, Other End-Users

Subsegments:

1) By Transcriptional: DNA Methylation, Histone Modification

2) By Post-Transcriptional: RNA Interference (RNAi), Antisense Oligonucleotides, MicroRNA (miRNA) Mediated Silencing

3) By Meiotic: Meiotic Gene Conversion, Transposable Element Silencing

Which Market Trends Are Expected To Define The Future Of The Gene Silencing Market?

Key players in the gene silencing market are concentrating on creating groundbreaking technologies like small interfering RNA (siRNA) for enhancing accuracy and efficiency in gene therapy. Small interfering RNA is a class of RNA molecules that impact the RNA interference (RNAi) pathway crucially by targeting specific messenger RNA (mRNA) and instigating its disintegration, blocking the proliferation of proteins causing diseases. As an example, Judo Bio Inc., a biotech company based in the US, introduced siRNA, a novel drug in October 2024. It uses small interfering RNA (siRNA) to mute genes. This development sets itself apart with its patented delivery mechanisms like lipid nanoparticles or conjugated ligands that promise excellent absorption by specific cells or tissues and AI-powered platforms that speed up the identification of feasible gene targets.

Which Players Are Shaping The Competitive Landscape Of The Gene Silencing Market?

Major companies operating in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gene-silencing-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Gene Silencing Market?

North America was the largest region in the gene silencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene silencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24224&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model